Slide Presentation: Pharmacological treatment of overactive bladder – What can we hope to achieve? by Karl-Erik Andersson, MD, PhD

Dr. Andersson then explains that both overactive bladder (OAB) syndrome and detrusor overactivity (DO) are multifactorial disorders, while moving forward with a review of what is known about the pathways contributing to each disorder, the pathways for the pathophysiology of the disorders, and finally with a detailed review of the evidence for pharmacologic treatments and what may be possible for treatments in the future.